CV vs EG · rev $3.5M vs P/E 17, rev $17.28B
CapsoVision, Inc. Common Stock (CV) versus Everest Group Ltd (EG) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
CV currently screens at market cap $359.2M. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Not investment advice. Open the CV and EG stock pages for the full models.
Not investment advice.